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Indirect immunogold electron microscopy studies of 
cryofixed, freeze-substituted, and post-embedded 
normal human skin were performed to localize pre-
cisely the ultrastructural binding site of circulating 
autoantibodies from two groups of patients with 
cicatricial pemphigoid. One group of patients had 
circulating IgG autoantibodies that bound the dermal 
side of 1 M NaCI-split skin and immunoprecipitated 
epiligrin. The other group of patients had circulating 
IgG autoantibodies directed against the epidermal 
side of 1 M NaCI-split skin and showed no specific 
reactivity to any keratinocyte polypeptide by immu-
noprecipitation. IgG autoantibodies from all patients 
with anti-epiligrin cicatricial pemphigoid bound the 
lowermost aspect of the lamina lucida at its interface 
with the lamina densa; the greatest staining was seen 
beneath and beside hemidesmosomes. In contrast, 
IgG from cicatricial pemphigoid patients whose au-
toantibodies bound the epidermal side of 1 M N aCI-
atients with cicatricial pemphigoid (CP) characteristi-
cally have deposits of immunoglobulins (usually IgG 
and/ or IgA) and complement components in their 
epithelial basement membranes (BMs) [1,2]. Direct 
immunoelectron microscopy (IEM) studies using per-
oxidase-conjugated probes and pre-embedding staining techniques 
have shown that in situ immunoreactants in patients with CP are 
localized in the lamina lucida and along the lamina dens a of 
epidermal or mucosal BMs [3-6]. Some patients with CP have 
circulating autoantibodies directed against epidermal BM. How-
ever, when present, such autoantibodies are usually of low titer, 
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split skin localized to hemidesmosomes and the junc-
tion between hemidesmosomes and the plasma 
membranes of basal keratinocytes. Although the lat-
ter staining pattern is similar to that observed with 
anti-BPAG2 autoantibodies, sera from our patients 
with cicatricial pemphigoid did not bind BPAG2 in 
immunoprecipitation studies of radiolabeled human 
keratinocyte extracts or show immunoblot reactivity 
to a fusion protein corresponding to the immuno-
dominant epitope of this polypeptide. These studies 
demonstrate the following: 1) Autoantibodies from 
patients with anti-epiligrin cicatricial pemphigoid 
consistently bind the lower lamina lucida at its inter-
face with the lamina densa; and 2) other patients with 
the same phenotype may have IgG autoantibodies 
against yet-unknown epitopes in basal keratinocytes. 
K ey words: bullous diseases/ep iligrin /autoimmunity'ultra-
structure. ] Invest D ermatol 104:370-373, 1995 
and it has been difficult to localize precisely their binding site(s) in 
epidermal BM by indirect IEM. 
Recent studies have identified a group of patients with a form of 
CP who have circulating IgG autoantibodies that bind the dermal 
side of 1 M NaCl-split skin (SSS) and immunoprecipitate a 
keratinocyte-derived glycoprotein complex termed epiligrin [7,8]. 
Epiligrin is an integrin ligand and laminin isoform that is clo sely 
related, if not identical, to laminin 5 (the latter formerly called 
kalinin, nicein, or BM 600). Other patients w ith CP have been 
identified who have circulating IgG autoantibodies that bind the 
epidermal side of SSS and do not recognize epiligrin or other 
human keratinocyte antigens in traditional immunoprecipitation 
analyses. These findings (as well as other studies) suggest that CP is 
a disease phenotype rather than a single nosologic entity [8,9]. In 
the current investigation, we performed indirect immunogold 
electron microscopy studies of cryofixed, freeze- substituted, and 
postembedded normal human skin to localize precisely the portion 
of epidermal BM targeted by IgG autoantibodies in patients w ith 
antiepiligrin C Po T hese findings are compared w ith those obtained 
using sera from CP patients who do not have antiepiligrin autoan-
tibodies. To our know ledge, this is the firs t indirect immunogold 
electron microscopy study to localize precisely the binding site (s) of 
0022- 202X/95/$09 .50 • SSD I0022-202X(94)00374-G • Copyright © 1995 by The Society for Investigative Dermatology, Inc. 
370 
VOL. 104, NO. 3 MARCH 1995 
autoantibodies from patients with CP in cryofixed, freeze-substi-
tuted, and postembedded human skin. 
MATERIALS AND METHODS 
Patients We studied three patients with clinical features of CP, in situ 
deposits of IgG and C3 in epidermal BM, and circulating IgG anti-BM 
autoantibodies that immunoprecipitated epiligrin. Two clinically indistin-
guishable CP patients with deposits of immunoreactants in their epidermal 
BM and circulating IgG anti-BM autoantibodies that did not immunopre-
cipitate epiligrin were also studied. Summary data regarding clinical and 
immunopathologic findings in these patients are presented in Table I and 
have been described in part previously [8] . In addition, sera from normal 
volunteers and from well-characterized patients with bullous pemphigoid 
(BP) or epidermolysis bullosa acquisita were used as control reagents in 
indirect immunofluorescence microscopy, immunoprecipitation, and/or 
immunogold electron microscopy experiments, as described below. 
Immunofluorescence Microscopy Direct immunofluorescence mi-
croscopy of normal-appearing, perilesional skin was performed using fluo-
rescein-isothiocyanate-conjugated goat antibodies directed against human 
IgG, IgA, IgM, IgE, or fibrinogen (all from Tago Inc., Burlingame, CA) as 
well as rabbit anti-human C3c (Dako Corp., Glostrup, Denmark), as 
described previously [10]. Sera from patients with CP, normal volunteers 
(negative controls), and well-characterized individuals with BP or epider-
molysis bullosa acquisita (positive controls) were tested against intact skin or 
SSS by indirect immunofluorescence microscopy, as described previously 
[10]. 
Immunoprecipitation To define further the antigens targeted by the 
patients' autoantibodies, their sera were tested against conditioned media 
and extracts of radiolabeled human keratinocytes using a previously de-
scribed immunoprecipitation technique [11,12] . In these experiments, 
keratinocyte extracts were prepared with a standard as well as a specialized 
extraction buffer to enhance detection of BP antigen 2 (BPAG2, also 
referred to as BP180 or type XVII collagen) [11 - 13]. All serum samples 
were tested in duplicate against these three sources of radiolabeled kerati-
nocyte antigens (i.e., conditioned media and two types of cell extracts). 
Controls in these stJdies included sera from normal volunteers and from BP 
patients with circulating IgG autoantibodies directed against BPAGl (i.e., 
BP 230) and BPAG2. Immunoprecipitation samples were analyzed by 
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
fluorography, as described previously [12]. 
IEM With Cryofixation and Freeze Substitution We performed 
postembedding immunogold electron microscopy using cryofixation and 
cryosubstitution without chemical fixatives to study the ultrastructural 
binding site of the patients' autoantibodies to normal human skin, as 
described previously [14 - 16] with slight modification [17]. In brief, normal 
skin samples were obtained from the abdomen of healthy adults and 
immediately cut into small pieces (less than 1 mm3 ). Skin samples were 
frozen rapidly by plunging into liquid propane, cooled to -190°C, at a 
speed of 3 m /s using a KF- 80 freeze-plunging apparatus (Reichert jung, 
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Vienna, Austria). Frozen skin samples were next cryosubstituted with 100% 
acetone at - 80°C for 120 h, then embedded in Lowicryl K11M (Chemische 
Werke Lowi, Waldkraiburg, Germany) at - 60°C. Polymerization of 
embedded samples was initiated under ultraviolet radiation at - 60°C for 72 
h and continued at room temperature for an additional 72 h. Ultrathin skin 
sections were cut and incubated overnight at 4°C with respective serum 
samples (diluted 1:40). After washing, samples were placed on a drop of 5 
nm gold-labeled goat anti-human IgG (heavy- and light-chain specific, 
diluted 1 :50; Amersham International, Amersham, Buckinghamshire, UK) 
and incubated for 2 h at room temperature. Mter extensive washing of 
sections, gold particles were enhanced by silver staining. Sections were 
counterstained with uranyl acetate and lead citrate and then studied with a 
transmission electron microscope. 
RESULTS 
Table I presents the major clinical and immunopathologic findings 
from the patients in this study. In brief, patients 1, 2, and 3 had 
subepithelial bullous lesions of the mucous membranes and skin, in, 
situ deposits of IgG and C3 in epidermal BM, and circulating IgG 
autoantibodies against the dermal side ofSSS. Sera from all of these 
patients immunoprecipitated a set of disulfide-linked polypeptides 
of 170, 145, 125, and 95 k.D in radiolabeled keratinocyte media. 
Comparative immunoprecipitation and preclearance studies have 
shown that this set of polypeptides comigrates in SDS-PAGE with 
the same complex identified by monoclonal antiepiligrin antibody 
P1E1; these patients have thus been termed to have antiepiligrin 
CP. Patients 4 and 5 had subepithelial bullous lesions of the mucous 
membranes and skin, in situ deposits of immunoreactants in epider-
mal BM, and circulating IgG anti-BM autoantibodies against the 
epidermal side of SSS. These patients' circulating autoantibodies 
did not recognize any distinct antigen in immunoprecipitation 
studies of radiolabeled keratinocyte media or cell extracts. 
Indirect immunogold electron microscopy studies of circulating 
IgG anti-BM autoantibodies from patients 1, 2, and 3 all showed 
the same pattern of staining. In these studies, the majority of gold 
particles (70%) localized between the lower half of the lamina 
lucida and the upper surface of the lamina densa (Fig 1A-q. More 
gold particles were observed beneath and beside hemidesmosomes, 
although reactivity was not restricted to these sites. None of these 
patients' autoantibodies specifically bound the cytoplasm, hemides-
mosomes, or plasma membranes of basal keratinocytes; moreover, 
there was no specific binding of gold particles to anchoring fibrils or 
to the sublamina densa region. 
In contrast to the findings on patients with antiepiligrin CP, 
autoantibodies from patients 4 and 5 bound along the junction 
between hemidesmosomes and plasma membranes of basal kerati-
nocytes (Fig 2A,B). These patients' autoantibodies showed no 
Table I. Clinical and Immunopathologic Findings in CP Patients 
Patient IIF IIF 
Age (years) Sites of Erosive/ Intact Split 
and Sex Bullous Lesions DIFfl Skin" Skin' Ipd 
Patient 1, Oral, nasal , and conjunctival mucosa; IgG and C3 20 320; dermal Epiligrin 
39/female legs 
Patient 2, Oral, nasopharyngeal , laryngeal, conjunc- IgG and C3 10 160; dermal Epiligrin 
29/male tival, and genital mucosa; face, scalp, 
upper back, and perianal region 
Patient 3, Oral, nasopharyngeal, conjunctival, IgG and C3 Negative 160; dermal Ep ili grin 
621male esophageal, and genital mucosa; trunk 
Patient 4, Oral mucosa and scalp C3 5 80; epidermal Negative 
54/male 
Patient 5, Oral and laryngeal mucosa IgG and C3 5 10; epidermal Negativec 
58/male 
a DIF, direct immunofluorescence microscopy. 
b IIF intact skin: patient's IgG autoantibody titer against intact normal human skin by indirect immunofluorescence microscopy. 
r IIF split skin: patient' s IgG autoantibody titer against 1 M NaCI-split normal human skin by indirect immunofluorescence microscopy. 
d IP, Immunoprecipitation. These results signify reactivity of these patients' sera against radiolabeled human keratinocyte media and cell extracts (prepared with standard as well 
as specialized extraction buffers to enhance detection ofBPAG2; i.e., three separate studies were performed on all samples in duplicate). 
e Although this patient' s serum does not immwlOprecipitate BPAG2 or react with a fusion protein corresponding to the immunodominant epitope of this molecule, it does 
immunoblot a 180-kD epidermal protein that comigrates with BPAG2 in SDS-PAGE (see Discussion). 
372 SHIMIZU ET AL 
Figure 1. IgG autoantibodies from patients with antiepiligrin CP 
bind the lower half of the lamina lucida and the upper surface of 
the lamina densa. Patient 1, A; patient 2, B; patient 3, C. Binding of these 
patients' autoantibodies predominates beneath and beside hemidesmo-
somes. There is no specific binding of gold particles to the cytoplasm, 
hemidesmosomes, or plasma membranes of basal keratinocytes or to sites in 
the sublamina densa region. Bars, 100 run. 
specific binding to the lower half of the lamina lucida, the lamina 
densa, or the sublamina densa region. 
In control studies (data not shown), indirect immunogold elec-
tron microscopy of patient IgG autoantibodies directed against 
BPAG 1 found that gold particles bound only the intracellular 
portion of hemidesmosomes of basal keratinocytes. T~s previ.ously 
described pattern (16] is different from that observed ill studIes of 
autoantibodies from any of our patients with CPo However, studies 
of anti-BPAG2 autoantibodies showed binding of gold particles to 
hemidesmosomes and plasma membranes of basal keratinocytes 
[16] in a pattern similar to that observed in irnmunogold electron 
microscopy studies of autoantibodies from our patients 4 and 5. 
This is an interesting finding considering that these patients' sera 
showed no evidence of reactivity to BPAG2 by irnmunoprecipita-
tion (see Discussion). Additional control studies of autoantibodies 
from a patient with epidermolysis bullosa acquisita showed immu-
nogold labeling of lamina densa and anchoring fibrils in a pattern 
clearly different from that observed in our studies of CP patients. 
Normal human sera (negative controls) showed no specific binding 
of gold particles to postern bedded human skin sections. 
DISCUSSION 
Epiligrin was originally described as a glycoprotein complex in human-
keratinocyte extracellular matrix and was named for its role as the 
major integrin ligand of human epidermal cells [18]. In vitro, epiligrin 
has been shown to bind integrin cx3f31 in focal adhesions and to 
colocalize with integrin cx6f34 in hemidesmosome-like stable anchoring 
complexes on the plasma membranes of human keratinocytes. Re-
cendy, Ryan et al [19] reported that epiligrin is a laminin isoform. 
Moreover, these investigators isolated at least two distinct cDNA 
clones corresponding to the cx chain of epiligrin and also identified its 
genomic clone. Although the exact utilization of these splice variants 
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Figure 2. Sera from CP patients with IgG autoantibodies directed 
against the epidermal side of SSS bind along the junction between 
hemidesmosomes and plasma membranes of basal keratinocytes. 
Patient 4, A; patient 5, B. These patients' autoantibodies show no specific 
binding to the lower half of the lamina lucida, the lamina densa, or the 
sublamina densa region. Bars , 100 nm . 
in various laminin isoforms is not yet resolved, there is general 
agreement that epiligrin is closely related, if not identical, to laminin 5 
(a laminin isoform formerly called kalinin, nicein, or BM 600) [19-22]. 
In human skin, epiligrin and larninin 5 have been localized to the 
lamina lucida of human epidermal BM, where this laminin isoform is 
thought to be associated with anchoring filaments [18-20]. Re.cent~y, 
a form of CP has been identified as demonstrating IgG autoantibodIes 
that immunoprecipitate a set of disulfide-linked keratinocyte polypep-
tides that comigrate in SDS-PAGE with the same complex recognized 
by monoclonal antibodies directed against epiligrin or laminin 5 [7,8]. 
Moreover, Kirtschig et al showed that sera from five of five CP 
patients with antiepiligrin autoantibodies specifically bo~d t~e .cx 
chain of this laminin isoform:j:-interestingly, the polypeptide Within 
this heterotrirner that is thought to play a key role in binding kera-
tinocytes to extracellular matrix in vitro and to epidermal BM in vivo. 
In this indirect irnmunogold electron microscopy study, sera 
from all patients with antiepiligrin autoantibodies bound to the 
lower aspect of the lamina lucida at its interface with the lamina 
densa. Although the gold particles did not strictly localize the 
reactivity of these autoantibodies to the epidermal BM beneath 
hemidesmosomes, there was greater staining below and beside this 
adhesion unit. In contrast, autoantibodies from other patients with 
CP bound hemidesmosomes and the junction between hemides-
:j: Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB: Sera from 
cicatricial pemphigoid patients with anti-epiligrin autoantibodies irnmuno-
blot the 165 kD subunit ofkalinin (abstr) . ] Invest Dermatoll02:558, 1994. 
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mosomes and plasma membranes in basal keratinocytes, in keeping 
with their reactivity against the epidermal side of SSS. Sera from 
another CP patient with clinical and immunopathologic findings 
like those of subjects 4 and 5 were not studied successfully by 
indirect immunogold electron microscopy, presumably because of 
the low titer of his circulating IgG anti-BM autoantibodies (specif-
ically, a titer of 2.5 against SSS; data not shown). It is interesting 
that IgG from patients 4 and 5 bound epidermal BM in a pattern 
much like that seen in immunogold electron microscopy studies of 
autoantibodies directed against BPAG2 [16]. As noted previously, 
the sera of patients 4 and 5 had no reactivity against BPAG 1, 
BPAG2, or other antigens in keratinocyte extracts or media in our 
immunoprecipitation studies. The findings in our indirect immu-
no gold electron microscopy studies of patients 4 and 5 may signify 
reactivity of their autoantibodies to some other target antigen(s) in 
basal keratinocytes. To address this possibility, we studied the 
reactivity of these patients' sera against an extract of normal human 
epidermis [23] or a fusion protein corresponding to the immuno-
dominant epitope of BPAG2 [24]§ by immunoblotting. In these 
studies, we found that serum from patient 4 showed no reactivity to 
antigens in the epidermal extract or the BPAG2 fusion protein-
findings consistent with the idea that this patient's autoantibodies 
were targeting some yet to be defmed keratinocyte antigen. 
Although the serum of patient 5 immunoblotted a 180-kD epider-
mal protein that comigrated with BPAG2 in SDS-PAGE, this 
patient's serum showed no reactivity to the BPAG2 fusion protein. 
These findings are consistent with reactivity against a "minor" 
BPAG2 epitope or an alternate 180-kD keratinocyte polypeptide. It 
is interesting that Bernard et al [25] also found recently that 
autoantibodies from some patients with CP recognize a similar 
keratinocyte polypeptide (i.e., a 180-kD polypeptide that shows 
immunologic cross-reactivity with BPAG2). 
The rarity of CP, the infrequency of circulating autoantibodies in 
these patients, and their low titers when present have greatly limited 
indirect IEM studies of patients with this disease. Apart from our 
investigations, we are aware of only nine patients with CP whose 
autoantibodies have been studied successively by indirect IEM; more-
over, all such studies were performed with peroxidase-co~ugated 
second-step antibodies and pre-embedding staining techniques. In the 
largest previous study, Bedane et at [26] used saponin-treated and 
untreated skin to show that sera from eight patients with CP contained 
IgG autoantibodies that bound to the lower lamina lucida and the 
lamina densa of epidermal BM in regularly spaced clumps. These 
investigators suggested that the "CP antigen" differs from BP antigens 
by its exclusive extracellular location in the deeper portion of the 
lamina lucida. Although these results are similar to our fmdings in 
patients with antiepiligrin CP, autoantibodies in the previous series 
[26] were noted to bind the epidermal side of SSS and to immunoblot 
240-KD and/or l80-kD polypeptides in keratinocyte extracts-results 
not observed in any of our patients with antiepiligrin autoantibodies. In 
a case report, Horiguchi et at [27] found that a CP patient's autoanti-
bodies bound exclusively to the dermal side of SSS by indirect 
immunofluorescence microscopy and localized to the lower half of the 
lamina lucida and the lamina dens a by indirect IEM. However, such 
findings are again paradoxical because this patient's sera immtilloblot-
ted BPAGl, an intracellular component ofhemidesmosomes in basal 
keratinocytes. Considering the small number of patients that have 
been studied to date, it is understandable that differences have been 
noted. One hopes that additional studies correlating clinical and 
laboratory findings will clarify this disease phenotype and lead to the 
identification and characterization of antigens specifically targeted by 
autoantibodies from patients with various forms of CPo 
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